Characterization of the novel plasmid-encoded MBL gene <i>bla</i><sub>AFM-1</sub>, integrated into a <i>bla</i><sub>IMP-45</sub>-bearing transposon Tn<i>6485e</i> in a carbapenem-resistant <i>Pseudomonas aeruginosa</i> clinical isolate

Xuefei Zhang,Leilei Wang,Dan Li,Chen Wang,Qinglan Guo,Minggui Wang
DOI: https://doi.org/10.1093/jac/dkab342
2022-01-01
Abstract:Objectives: To characterize the novel subclass B1 MBL AFM-1, encoded by a bla(IMP-45)-bearing megaplasmid from a carbapenem-resistant Pseudomonas aeruginosa (CRPA) clinical isolate. Methods: CRPA HS17-127 and its transconjugant were discovered to carry bla(AFM-1) in our previous study. bla(AFM-1) and bla(NDM-1) were cloned and expressed in Escherichia coli TOP10 and P. aeruginosa PAO1, respectively, to test the resistance phenotype. Kinetic studies were performed to elucidate the biochemical characteristics of the AFM-1 enzyme. Comparative genomic analysiswas applied to investigate the genetic context of bla(AFM-1). Results: PAO1 transconjugant TcHS17-127 exhibited carbapenem resistance with an imipenem MIC of 64 mg/L. E. coli transformants with cloned bla(AFM-1) or bla(NDM-1) had increased MICs of all beta-lactams tested (except aztreonam) and imipenem MICs of 4-8 mg/L. Kinetic studies showed that AFM-1 had greater catalytic efficiency against cephalosporins than carbapenems. bla(AFM-1) was located on a 486 963 bp IncP-2 plasmid, pHS17-127, containing a 57.3 kb MDR Tn1403-derivative transposon, Tn6485e, which is genetically closest to the bla(IMP-45) bearing Tn6485 transposon but has acquired an extra ISCR27n3-bla(AFM-1) module. Multicentre surveillance of 605 P. aeruginosa clinical isolates identified three bla(AFM) carriers from different STs. Two of them co-carried bla(AFM-1) and bla(IMP-45). A BLAST search against the NCBI database showed six bla(AFM) carriers on various plasmids and the chromosomes of different Gram-negative species. Conclusions: The bla(AFM-1) gene confers carbapenem resistance and has been captured in distinct species of non-fermenters. Co-carriage of bla(AFM-1) and bla(IMP-45) in an MDR transposon on a conjugative plasmid can be expected to promote further dissemination of bla(MBL)s.
What problem does this paper attempt to address?